Additionally, enzymes involved in purine metabolism have also been proposed as potential drug targets for BC, and these include the ribonucleotide reductase regulatory subunit M2 (RRM2), natriuretic peptide receptor 1 (NPR1,) and phosphodiesterases (PDE) enzymes [54,85]. Here, NPR1 is linked to breast cancer.